Merck Global Health Innovation Fund and existing investor Cedars-Sinai took part in a $17m round for the blood collection technology provider.

Jackson State University will helm the Enrich initiative to engage health innovators from 25 historically-black US colleges and universities.

Tübingen's messenger RNA vaccine and drug developer's latest round includes a $171m investment by strategic partner GlaxoSmithKline.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The messenger RNA vaccine and drug developer's latest round includes a $171m investment by strategic partner GlaxoSmithKline.

UC Berkeley's genetic drug developer 4DMT has pulled away from a proposed $100m offering after closing series C funding last month.

Mingdu Intelligent, backed by three Chinese academic institutions, has increased its funding haul to at least $26m.

Vesigen has attracted Leaps by Bayer to commercialise drug delivery technology invented by Quan Lu at Harvard School of Public Health.

GV had led an oversubscribed series D round for the gene therapy developer that also featured Illumina Ventures and SoftBank Vision Fund II.

Pfizer and Chiesi-backed genetic drug developer 4DMT has pulled away from a proposed $100m offering after closing series C funding last month.